ACTRN12614000312640
Completed
未知
Predictors of treatment outcome (symptom severity) for mildly to moderately depressed patients in guided self-help vs. contact-on-demand online-interventions
Freie Universitaet Berlin0 sites500 target enrollmentMarch 25, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Freie Universitaet Berlin
- Enrollment
- 500
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •German\-speaking adults suffering from depression with access to the internet
Exclusion Criteria
- •Schizophrenia, schizotypal and delusional disorders (F20\-F29\)
- •Sucidal participants
- •Severely depressed participants
- •Patients in concurrent psychotherapeutic treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancerColorectal cancerJPRN-UMIN000021191Juntendo University Faculty of Medicine60
Completed
Not Applicable
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma,topotecan,induction therapy,treatment response,prognostic factor,treatment-related toxicityTCTR20190602002Phramongkutklao Hospital and College of Medicine107
Not yet recruiting
Not Applicable
Clinical Outcomes and Treatment Compliance in Osteosarcoma Cases Treated With Low Cost Protocol in a Tertiary Care Cancer Center in India.CTRI/2023/10/059247Tata Memorial Centre
Completed
Not Applicable
Prognostic parameter in patients having therapy-related myeloid neoplasms after peptide receptor radionuclide therapy (PRRT) and peptide receptor radioligand therapy (PRLT) over 20 years’ experiencetherapy-related myeloid neoplasmpeptide receptor radionuclide therapyrelated myeloid neoplasm,prognostic factor,peptide receptor radionuclide therapy,overall survival,predictor,myelodysplastic syndromeTCTR20200428005one386
Recruiting
Not Applicable
Verification of therapeutic effects and prognosis by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patientsJPRN-UMIN000050323Fukunagakinen Clinic30